A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: Colesevelam HCL

Ronald B. Goldberg

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: Colesevelam HCL'. Together they form a unique fingerprint.